General Facts and Figures Classification Presentation History Physical Exam Labs Radiology Diagnosis Criteria for diagnosis Differential Microbiology General Specific organisms Pharmacology Drug Classes Mechanism of action Resistance Treatment General Site of care Medication Duration Assessment of responce Prevention References Literature cited Complete bibliography Links More...		Treatment Prevention the Advisory Committee on Immunization Practices (ACIP) recommends pneumococcal vaccination (Pneumovax) for the following persons: age 65 years or older; with chronic heart, lung or liver disease; with diabetes; with immunologic disorders or who are immunocompromised (cancer patients, persons with HIV infection, organ transplants, and those receiving steroids, chemotherapy, or radiation therapy); who have had their spleen removed or have dysfunction of the spleen due to sickle cell anemia; who have a leakage of spinal fluid, or nephrotic syndrome (a chronic kidney condition that causes loss of protein through the urine), with organ or bone marrow transplants, with chronic kidney failure (see CDC - Prevention of Pneumococcal Disease: Recommendations of ACIP) influenza vaccine (see CDC - Prevention and Control of Influenza: Recommendations of ACIP) no other vaccines are currently available

medschool.ucsd.edu/curricular_resources/MED/CAP/index.html   3/30/99